Safe Biologics

In Business Facilities Magazine’s 2009 Biotechnology Strength Report released last fall, Ohio is once again ranked fourth among all states. California claimed top ranking, followed by Massachusetts, Pennsylvania, and Ohio.  Maryland, Texas, New Jersey, Illinois, Kansas, and North Carolina rounded out the top 10.
Read More

June 7-8, 2011
Millennium Plaza, United Nations
New York, NY
Read More

June 3, 2011
Crowne Plaza Hotel
Syracuse, NY
Read More

April 6-7, 2011
New York Marriott Marquis
New York, NY
Read More

As the only statewide association in New York State dedicated solely to the issues of the bioscience industry, NYBA urges legislators to support the industry by focusing on issues that will create a better business climate that will allow companies at all stages of development to grow and succeed. NYBA is committed to policies that ensure patient access to the innovative therapies, devices and diagnostics that are being developed by the many bioscience companies across New York.
Read More

The New York Academy of Sciences, in conjunction with the FDA and the National Institute for Standards and Technology (NIST), held a workshop on December 12–14, 2005 that focused on the scientific issues involved in assessing the similarity of follow-on protein products. At the conference, scientists from academe, industry, and government surveyed the scientific issues surrounding protein structure and function, focusing on specific analytical methodologies for characterizing protein products.
Read More

The State Biotechnology Industry Briefing is a PowerPoint presentation on the New York biotech industry that is made available to NYBA constituents for use in promoting the industry to a wider audience. Educators, analysts, business executives, entrepreneurs, financiers and others have used information from our industry briefings in various presentations relating to the industry.
Read More

September 19-21, 2011
Seaport World Trade Center
Boston, MA
Read More